Tuberculosis Treatment Completion Rates in Southern New Mexico Colonias

被引:0
作者
Holden, Maria Arroyo [1 ]
Huttlinger, Kathleen [2 ]
Schultz, Pamela [2 ]
Mullins, Iris [3 ]
Forster-Cox, Sue [4 ]
机构
[1] Univ Colorado, Beth El Coll Nursing & Hlth Sci, Colorado Springs, CO 80907 USA
[2] New Mexico State Univ, Sch Nursing, Las Cruces, NM 88003 USA
[3] Radford Univ, Sch Nursing, Radford, VA 24142 USA
[4] New Mexico State Univ, Coll Hlth & Social Serv, Las Cruces, NM 88003 USA
关键词
Tuberculosis; New Mexico-Mexico border; Colonias;
D O I
10.1007/s10903-015-0207-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
TB medication completion treatment rates for active TB patients living in impoverished US-Mexico border communities called colonias in southern New Mexico counties are unknown. It might be suspected that residents of colonias have lower completion rates than those living in incorporated and medically more accessible areas. A retrospective record review of closed TB case records from 1993 to 2010 of southern New Mexico border counties, was conducted using a modified version of the New Mexico Department of Health Tuberculosis Targeted Health Assessment/History form (Appendix 1). Study findings reveal that despite their unincorporated status, poorer living conditions and questionable legal status, colonia TB patients had a higher medication completion rate than their non-colonia counterparts. A robust New Mexico TB treatment program contributed to high completion rates with death being the number-one reason for treatment non-completion in both colonia and non-colonias.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 50 条
  • [21] High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel
    Bishara, Hashem
    Ore, Liora
    Armaly, R. N. Najat
    Ravell, Daniel Weiler
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [22] Tuberculosis cases in Wisconsin: Documentation of treatment improvement and completion of treatment, 2000-2002
    Monteon, ML
    Arcari, CM
    Remington, PL
    Kanarek, MS
    Oemig, TV
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2006, 12 (03) : 254 - 261
  • [23] Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion
    van der Zalm, Marieke M.
    Jongen, Vita W.
    Swanepoel, Ruan
    Zimri, Klassina
    Allwood, Brian
    Palmer, Megan
    Dunbar, Rory
    Goussard, Pierre
    Schaaf, H. Simon
    Hesseling, Anneke C.
    Seddon, James A.
    ECLINICALMEDICINE, 2024, 67
  • [24] Current status of treatment completion and fatality among tuberculosis patients in Spain
    Caylà, JA
    Caminero, JA
    Rey, R
    Lara, N
    Vallés, X
    Galdós-Tangüis, H
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (04) : 458 - 464
  • [25] Treatment of tuberculosis: what is new?
    Brehm, Thomas Theo
    Koehler, Niklas
    Schmiedel, Stefan
    Terhalle, Elena
    Martensen, Julia
    Kalsdorf, Barbara
    Kandulla, Janne
    Heyckendorf, Jan
    Kuhns, Martin
    Friesen, Inna
    Lange, Christoph
    INNERE MEDIZIN, 2023, : 701 - 707
  • [26] New horizons in the treatment of tuberculosis
    Barry, CE
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (11) : 1165 - 1172
  • [27] A new treatment approach in tuberculosis
    Helvaci, Mehmet Rami
    Akkucuk, Seckin
    Aydogan, Akin
    WORLD FAMILY MEDICINE, 2013, 11 (10): : 33 - 36
  • [28] New drugs for treatment of tuberculosis
    Schaberg, T.
    INTERNIST, 2016, 57 (02): : 136 - 141
  • [29] New Drugs for the Treatment of Tuberculosis
    Ignatius, Elisa H.
    Dooley, Kelly E.
    CLINICS IN CHEST MEDICINE, 2019, 40 (04) : 811 - +
  • [30] Fluoroquinolones: a new treatment for tuberculosis?
    Gillespie, SH
    Kennedy, N
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (04) : 265 - 271